Cargando…
Using iPS Cells toward the Understanding of Parkinson’s Disease
Cellular reprogramming of somatic cells to human pluripotent stem cells (iPSC) represents an efficient tool for in vitro modeling of human brain diseases and provides an innovative opportunity in the identification of new therapeutic drugs. Patient-specific iPSC can be differentiated into disease-re...
Autores principales: | Torrent, Roger, De Angelis Rigotti, Francesca, Dell’Era, Patrizia, Memo, Maurizio, Raya, Angel, Consiglio, Antonella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470155/ https://www.ncbi.nlm.nih.gov/pubmed/26239346 http://dx.doi.org/10.3390/jcm4040548 |
Ejemplares similares
-
Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease
por: Sánchez-Danés, Adriana, et al.
Publicado: (2012) -
Understanding the mysteries of iPS cells
por: Cohen, Justin Brent, et al.
Publicado: (2009) -
ELM: A New, Simple, and Economic Assay to Measure Motility of Lymphatic Endothelial Cells
por: Torri, Fabio, et al.
Publicado: (2017) -
EBF1 is expressed in pericytes and contributes to pericyte cell commitment
por: Pagani, Francesca, et al.
Publicado: (2021) -
Phage Displayed Peptides/Antibodies Recognizing Growth Factors and Their Tyrosine Kinase Receptors as Tools for Anti-Cancer Therapeutics
por: Ronca, Roberto, et al.
Publicado: (2012)